171 related articles for article (PubMed ID: 18952584)
21. Recent advances in the treatment of childhood brain tumors.
Khatua S; Jalali R
Pediatr Hematol Oncol; 2005; 22(5):361-71. PubMed ID: 16020126
[TBL] [Abstract][Full Text] [Related]
22. Advances in treatment of pediatric brain tumors.
Robertson PL
NeuroRx; 2006 Apr; 3(2):276-91. PubMed ID: 16554265
[TBL] [Abstract][Full Text] [Related]
23. Evolving of therapeutic strategies for CNS-PNET.
Massimino M; Gandola L; Biassoni V; Spreafico F; Schiavello E; Poggi G; Pecori E; Vajna De Pava M; Modena P; Antonelli M; Giangaspero F
Pediatr Blood Cancer; 2013 Dec; 60(12):2031-5. PubMed ID: 23852767
[TBL] [Abstract][Full Text] [Related]
24. Radiotherapy for brain metastases.
Den RB; Andrews DW
Neurosurg Clin N Am; 2011 Jan; 22(1):37-44, vi. PubMed ID: 21109147
[TBL] [Abstract][Full Text] [Related]
25. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
Gnekow AK; Kortmann RD; Pietsch T; Emser A
Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548
[TBL] [Abstract][Full Text] [Related]
26. Cellular signaling molecules as therapeutic targets in glioblastoma multiforme.
Jagannathan J; Prevedello DM; Dumont AS; Laws ER
Neurosurg Focus; 2006 Apr; 20(4):E8. PubMed ID: 16709039
[TBL] [Abstract][Full Text] [Related]
27. Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers.
Korshunov A; Ryzhova M; Hovestadt V; Bender S; Sturm D; Capper D; Meyer J; Schrimpf D; Kool M; Northcott PA; Zheludkova O; Milde T; Witt O; Kulozik AE; Reifenberger G; Jabado N; Perry A; Lichter P; von Deimling A; Pfister SM; Jones DT
Acta Neuropathol; 2015 May; 129(5):669-78. PubMed ID: 25752754
[TBL] [Abstract][Full Text] [Related]
28. [Improved prognosis of intracranial germ cell tumors by intensified therapy: results of the MAKEI 89 therapy protocol].
Göbel U; Bamberg M; Calaminus G; Gnekow AK; Herrmann HD; Lenard HG; Spaar HJ; Niethammer D; Kühl J; Harms D
Klin Padiatr; 1993; 205(4):217-24. PubMed ID: 7690863
[TBL] [Abstract][Full Text] [Related]
29. Role of radiotherapy in the treatment of gliomas.
Mehta N; Silverberg W
Expert Rev Neurother; 2005 Nov; 5(6 Suppl):S51-61. PubMed ID: 16274271
[TBL] [Abstract][Full Text] [Related]
30. Outcome of children with centrally reviewed low-grade gliomas treated with chemotherapy with or without radiotherapy on Children's Cancer Group high-grade glioma study CCG-945.
Fouladi M; Hunt DL; Pollack IF; Dueckers G; Burger PC; Becker LE; Yates AJ; Gilles FH; Davis RL; Boyett JM; Finlay JL
Cancer; 2003 Sep; 98(6):1243-52. PubMed ID: 12973849
[TBL] [Abstract][Full Text] [Related]
31. Non-AIDS primary CNS lymphoma: first example of a durable response in a primary brain tumor using enhanced chemotherapy delivery without cognitive loss and without radiotherapy.
Dahlborg SA; Henner WD; Crossen JR; Tableman CM; Petrillo A; Braziel R; Neuwelt EA
Cancer J Sci Am; 1996; 2(3):166-74. PubMed ID: 9166517
[TBL] [Abstract][Full Text] [Related]
32. Neuropsychological rehabilitation for survivors of childhood and adolescent brain tumors: a view of the past and a vision for a promising future.
Nazemi KJ; Butler RW
J Pediatr Rehabil Med; 2011; 4(1):37-46. PubMed ID: 21757809
[TBL] [Abstract][Full Text] [Related]
33. Primary brain tumors, delta 24 and tumor metabolism. Interview by Rona Williamson.
Gilbert MR
Expert Rev Neurother; 2013 Apr; 13(4):353-5. PubMed ID: 23545051
[TBL] [Abstract][Full Text] [Related]
34. [Treatment of children with malignant brain tumors].
Ushio Y; Kochi M
Gan To Kagaku Ryoho; 1999 Jul; 26(8):1076-82. PubMed ID: 10431579
[TBL] [Abstract][Full Text] [Related]
35. Recent developments and current concepts in medulloblastoma.
Gerber NU; Mynarek M; von Hoff K; Friedrich C; Resch A; Rutkowski S
Cancer Treat Rev; 2014 Apr; 40(3):356-65. PubMed ID: 24389035
[TBL] [Abstract][Full Text] [Related]
36. Systemic therapies for melanoma brain metastases: which drug for whom and when?
Ramanujam S; Schadendorf D; Long GV
Chin Clin Oncol; 2015 Jun; 4(2):25. PubMed ID: 26112811
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of vincristine and etoposide with escalating cyclophosphamide in poor-prognosis pediatric brain tumors.
Ziegler DS; Cohn RJ; McCowage G; Alvaro F; Oswald C; Mrongovius R; White L;
Neuro Oncol; 2006 Jan; 8(1):53-9. PubMed ID: 16443948
[TBL] [Abstract][Full Text] [Related]
38. Current treatment approaches for infants with malignant central nervous system tumors.
Lafay-Cousin L; Strother D
Oncologist; 2009 Apr; 14(4):433-44. PubMed ID: 19342475
[TBL] [Abstract][Full Text] [Related]
39. Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part II: Treatment-related late toxicity.
Kortmann RD; Timmermann B; Taylor RE; Scarzello G; Plasswilm L; Paulsen F; Jeremic B; Gnekow AK; Dieckmann K; Kay S; Bamberg M
Strahlenther Onkol; 2003 Sep; 179(9):585-97. PubMed ID: 14628124
[TBL] [Abstract][Full Text] [Related]
40. Standard treatment and experimental targeted drug therapy for recurrent glioblastoma multiforme.
Chang SM; Butowski NA; Sneed PK; Garner IV
Neurosurg Focus; 2006 Apr; 20(4):E4. PubMed ID: 16709035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
